In non-diabetic chronic nephropathies urinary protein excretion rate accurately predicts progression to end stage renal failure (ESRF).

被引:0
|
作者
Ruggenenti, P
Perna, A
Lanzoni, M
Remuzzi, G
机构
[1] MARIO NEGRI INST PHARMACOL RES,I-24100 BERGAMO,ITALY
[2] OSPED RIUNITI BERGAMO,I-24100 BERGAMO,ITALY
来源
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A0390 / A0390
页数:1
相关论文
共 50 条
  • [21] Skeletal Status Evaluated by Quantative Ultrasound (QUS) of Hand Phalanges-A One-Year Prospective Study in Diabetic and Non-Diabetic Patients with End-Stage Renal Failure (ESRF)
    Zywiec, Joanna
    Pluskiewicz, Wojciech
    Gumprecht, Janusz
    Skubala, Alina
    Nabrdalik, Katarzyna
    Iwachow, Boguslaw
    Grzeszczak, Wladyslaw
    Simonska-Cichocka, Edyta
    DIABETES, 2010, 59 : A594 - A594
  • [22] Comparison of skin conditions in diabetic versus non-diabetic end stage renal disease patients
    Ngo, B
    Smogorzewski, W
    Woodley, D
    Rendell, M
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB156 - AB156
  • [23] Coronary artery disease among diabetic and non-diabetic patients with end stage renal disease
    Varghese, K
    Cherian, G
    Abraham, MT
    Hayat, NJ
    Johny, KV
    RENAL FAILURE, 2001, 23 (05) : 669 - 677
  • [24] Increased urinary albumin excretion in non-diabetic CHF is associated with impaired renal function.
    Smilde, TD
    Nevis, G
    Voors, AA
    Van Veldhuisen, DJ
    Hillege, HL
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 173A - 173A
  • [25] EMPAGLIFLOZIN REDUCES OF INORGANIC PHOSPHATE EXCRETION IN NON-DIABETIC RATS WITH CHRONIC HEART FAILURE?
    Beresneva, Olga
    Kulikov, Aleksandr
    Parastaeva, Marina
    Okovityi, Sergey
    Ivkin, Dmitry
    Zubina, Irina
    Khasun, Mokhamad
    Kayukov, Ivan
    Kucher, Anatoly
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [26] CHRONIC AMBULATORY PERITONEAL-DIALYSIS (CAPD) FOR END-STAGE RENAL-FAILURE (ESRF)
    THOMSON, NM
    WALKER, RG
    WHITESIDE, G
    SCOTT, D
    ATKINS, RC
    KIDNEY INTERNATIONAL, 1979, 16 (02) : 240 - 240
  • [27] The arterial function in patients with end-stage renal failure (ESRF) on chronic dialysis therapy and after renal transplantation
    Tronina, Olga
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 195 - 196
  • [28] Growth hormone treatment in infants under 1 year of age with chronic renal failure (CRF) and end stage renal failure (ESRF)
    Mencarelli, F.
    Kiepe, D.
    Stringini, G.
    Cappa, M.
    Emma, F.
    PEDIATRIC NEPHROLOGY, 2008, 23 (09) : 1585 - 1585
  • [29] URINARY AMMONIUM EXCRETION, METABOLIC ACIDOSIS AND PROGRESSION TOWARD END-STAGE RENAL DISEASE
    Metzger, Marie
    Vallet, Marion
    Haymann, Jean-Philippe
    Flamant, Martin
    Vrtovsnik, Francois
    Boffa, Jean-Jacques
    Karras, Alexandre
    Froissart, Marc
    Stengel, Becdicte
    Houillier, Pascal
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 116 - 117
  • [30] Effect of losartan on proteinuria and urinary angiotensinogen excretion in non-diabetic patients with chronic kidney disease
    Lee, Yu-Ji
    Cho, Seong
    Kim, Sung Rok
    Jang, Hye Ryoun
    Lee, Jung Eun
    Huh, Wooseong
    Kim, Dae Joong
    Oh, Ha Young
    Kim, Yoon-Goo
    POSTGRADUATE MEDICAL JOURNAL, 2011, 87 (1032) : 664 - 669